» Articles » PMID: 22381086

Validation of Hospital Register-based Diagnosis of Parkinson's Disease

Overview
Journal Dan Med J
Specialty General Medicine
Date 2012 Mar 3
PMID 22381086
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Denmark has a long-standing tradition of maintaining one of the world's largest health science specialized register data bases as the National Hospital Register (NHR). To estimate the prevalence and incidence of diseases, the correctness of the diagnoses recorded is critical. Parkinson's disease (PD) is a neurodegenerative disorder and only 75-80% of patients with parkinsonism will have idiopathic PD (iPD). It is necessary to follow patients in order to determine if some of them will develop other neurodegenerative diseases and a one-time-only diagnostic code for iPD reported in the register may be incorrect.

Material And Methods: This was a large nationwide population-based study of risk factors for iPD, called Parkinson's disease in Denmark (PASIDA). We evaluated the iPD diagnosis reported in the NHR. Medical records with primary diagnoses of iPD from six neurological departments were collected and abstracted using a standardized system to review the diagnostic accuracy of the ICD codes.

Results: Among the 1,040 medical records abstracted, 857 (82.4%) patients met our criteria for iPD. 183(17.6%) of the patients suffered from other diagnoses such as atypical PD (66 patients), secondary PD (60 patients) and other diagnoses (46 patients).

Conclusion: Possibly only about 82% of the patients with the primary diagnosis of iPD in the Danish NHR actually suffered from iPD. To improve diagnostic validity, we appeal to update the ICD code and to identify the correct parkinsonian phenotype to reduce biased case sampling in register-based studies and appropriate treatment for these rare diseases.

Funding: This study was supported by a grant from the National Institutes of Environmental Health Sciences, USA (grant No R01 ES013717). The funding source had no role in the design or analysis of the study or in the decision to submit the manuscript for publication.

Trial Registration: Ethical approval: The study protocol was approved by the Danish Data Protection Agency (No 2006-41-7323) and by UCLA-IRB.

Citing Articles

Integrating Big Data, Artificial Intelligence, and motion analysis for emerging precision medicine applications in Parkinson's Disease.

Dipietro L, Eden U, Elkin-Frankston S, El-Hagrassy M, Camsari D, Ramos-Estebanez C J Big Data. 2024; 11(1):155.

PMID: 39493349 PMC: 11525280. DOI: 10.1186/s40537-024-01023-3.


The effect of influenza vaccination on the rate of dementia amongst older adults.

Appel A, Janbek J, Jensen-Dahm C, Laursen T, Waldemar G Eur J Neurol. 2024; 31(12):e16489.

PMID: 39370749 PMC: 11554864. DOI: 10.1111/ene.16489.


Genome-wide meta-analysis of short-tandem repeats for Parkinson's disease risk using genotype imputation.

Ohlei O, Paul K, Searles Nielsen S, Gmelin D, Dobricic V, Altmann V Brain Commun. 2024; 6(3):fcae146.

PMID: 38863574 PMC: 11166220. DOI: 10.1093/braincomms/fcae146.


Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up.

Gronkjaer C, Christensen R, Kondziella D, Benros M Nat Commun. 2023; 14(1):4235.

PMID: 37454151 PMC: 10349860. DOI: 10.1038/s41467-023-39973-6.


Parkinson's disease population-wide registries in the United States: Current and future opportunities.

Wu A, Wilson A Front Digit Health. 2023; 5:1149154.

PMID: 37035478 PMC: 10073707. DOI: 10.3389/fdgth.2023.1149154.


References
1.
Gilman S, Wenning G, Low P, Brooks D, Mathias C, Trojanowski J . Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008; 71(9):670-6. PMC: 2676993. DOI: 10.1212/01.wnl.0000324625.00404.15. View

2.
Hughes A, Ben-Shlomo Y, Daniel S, Lees A . What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992; 42(6):1142-6. DOI: 10.1212/wnl.42.6.1142. View

3.
Christine C, Aminoff M . Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance. Am J Med. 2004; 117(6):412-9. DOI: 10.1016/j.amjmed.2004.03.032. View

4.
Horowitz M, Greenamyre J . Gene-environment interactions in Parkinson's disease: the importance of animal modeling. Clin Pharmacol Ther. 2010; 88(4):467-74. PMC: 3085510. DOI: 10.1038/clpt.2010.138. View

5.
Stover N, Watts R . Corticobasal degeneration. Semin Neurol. 2001; 21(1):49-58. DOI: 10.1055/s-2001-13119. View